KLRK1 and neoplasm: Although these studies failed to inhibit the generation of soluble NKG2D ligands from the perspective of metalloproteinases, they blocked the hydrolysis of metalloproteinases and, to a certain extent, reversed the immune escape of tumor cells against NK cells, making them potential candidate immune checkpoints for future anti-tumor immunotherapy.